MEDIROM Healthcare Technologies Inc ADR [MRM] fell -23.14% so far this year. What now?

MEDIROM Healthcare Technologies Inc ADR [NASDAQ: MRM] price surged by 10.73 percent to reach at $0.19.

A sum of 14904401 shares traded at recent session while its average daily volume was at 2.36M shares. MEDIROM Healthcare Technologies Inc ADR shares reached a high of $2.08 and dropped to a low of $1.71 until finishing in the latest session at $1.96.

The one-year MRM stock forecast points to a potential upside of 60.8. The average equity rating for MRM stock is currently 1.00, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on MEDIROM Healthcare Technologies Inc ADR [MRM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRM shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Price to Book ratio for the last quarter was 2.61, with the Price to Cash per share for the same quarter was set at 0.27.

MRM Stock Performance Analysis:

MEDIROM Healthcare Technologies Inc ADR [MRM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.70. With this latest performance, MRM shares gained by 48.48% in over the last four-week period, additionally plugging by 139.05% over the last 6 months – not to mention a rise of 90.29% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MRM stock in for the last two-week period is set at 56.18, with the RSI for the last a single of trading hit 0.3329, and the three-weeks RSI is set at 0.2817 for MEDIROM Healthcare Technologies Inc ADR [MRM]. The present Moving Average for the last 50 days of trading for this stock 1.5429, while it was recorded at 1.8180 for the last single week of trading, and 1.3211 for the last 200 days.

Insight into MEDIROM Healthcare Technologies Inc ADR Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and MEDIROM Healthcare Technologies Inc ADR [MRM] shares currently have an operating margin of 0.13% and a Gross Margin at 27.11%. MEDIROM Healthcare Technologies Inc ADR’s Net Margin is presently recorded at 1.86%.

MEDIROM Healthcare Technologies Inc ADR (MRM) Capital Structure & Debt Analysis

According to recent financial data for MEDIROM Healthcare Technologies Inc ADR. ( MRM), the Return on Equity (ROE) stands at 23.48%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 1.83%, reflecting the company’s efficiency in generating profits from its assets. Additionally, MEDIROM Healthcare Technologies Inc ADR’s Return on Invested Capital (ROIC) is 5.04%, showcasing its effectiveness in deploying capital for earnings.

MEDIROM Healthcare Technologies Inc ADR (MRM) Efficiency & Liquidity Metrics

Based on MEDIROM Healthcare Technologies Inc ADR’s (MRM) latest financial statements, the Debt-to-Equity Ratio is 3.49%, indicating its reliance on debt financing relative to shareholder equity.

MEDIROM Healthcare Technologies Inc ADR (MRM) Efficiency & Liquidity Metrics

From an operational efficiency perspective, MEDIROM Healthcare Technologies Inc ADR. (MRM) effectively leverages its workforce, generating an average of $970.5 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.65% and a Quick Ratio of 0.61%, indicating strong ability to cover short-term liabilities.

MEDIROM Healthcare Technologies Inc ADR [MRM] Institutonal Ownership Details

There are presently around $2.69%, or 3.66%% of MRM stock, in the hands of institutional investors.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.